Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
35.22
+1.47 (4.36%)
Feb 21, 2025, 4:00 PM EST - Market closed
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of $2.02 billion as of February 21, 2025. Its market cap has increased by 49.50% in one year.
Market Cap
2.02B
Enterprise Value
542.93M
1-Year Change
49.50%
Ranking
Category
Stock Price
$35.22
Market Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from $919.00M to $2.02B, an increase of 119.58%. That is a compound annual growth rate of 7.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 2.02B | 7.68% |
| Dec 31, 2024 | 1.87B | 50.56% |
| Dec 29, 2023 | 1.24B | -19.33% |
| Dec 30, 2022 | 1.54B | -13.57% |
| Dec 31, 2021 | 1.79B | -40.52% |
| Dec 31, 2020 | 3.00B | 6.73% |
| Dec 31, 2019 | 2.81B | 4.81% |
| Dec 31, 2018 | 2.68B | -3.76% |
| Dec 29, 2017 | 2.79B | 58.97% |
| Dec 30, 2016 | 1.75B | -28.25% |
| Dec 31, 2015 | 2.44B | -37.12% |
| Dec 31, 2014 | 3.89B | 420.55% |
| Dec 31, 2013 | 746.50M | -18.77% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 796.66B |
| UnitedHealth Group | 421.92B |
| Johnson & Johnson | 388.90B |
| Novo Nordisk | 370.84B |
| AbbVie | 356.66B |
| Abbott Laboratories | 233.73B |
| AstraZeneca | 227.07B |
| Merck & Co. | 223.70B |